Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Torrent Pharmaceuticals Ltd announces Q2 FY 2018-19 Results

Posted On: 2018-11-05 12:47:23

Ahmedabad based Pharmaceuticals major, Torrent Pharmaceuticals Limited, today released its financial results for the Quarter and Half Year ended September 30th, 2018.

Key highlights: Q2 FY19 consolidated financials

- Revenues at Rs. 1,894 crores (YoY growth of 34%).

- India business (including acquired business) at Rs. 816 crores (up by 34% YoY).
- US revenues (including acquired business) at Rs. 394 crores (up by 54% YoY). 7 ANDAs were filed during the quarter. As on Sep 30th 2018, 35 ANDAs are pending approval and 5 tentative approvals have been received.

- Brazil revenues at Rs. 147 crores (up by 23% YoY).
- Germany revenues at Rs. 251 crores (up by 20% YoY).

- Gross margins at 71.1%, up by 0.6% (YoY).

- EBITDA at Rs. 478 crores (EBITDA margin of 25%), up by 18% (YoY). Adjusted for one time impact of product recall in US, the EBITDA growth is 24% (YoY) and EBITDA margin is 26.6%.

- Net profit at Rs. 179 crores as against Rs. 204 crores in Q2 FY18 after considering the following major items:

- Depreciation and amortization is higher by Rs. 68 crores on account of acquired business
- One time impact of product recall in US of Rs. 25 crores
- Lower hedging gains due to rupee depreciation.

- R&D spend at Rs. 136 crores against Rs . 107 crores in Q2 FY18.

Key highlights: Hl FY19 consolidated financials

- Revenues at Rs 3,766 crores, up by 36% over Hl FY18.
- Gross margins at 70.6%, up by 0.1% over Hl FY18.
- EBITDA at Rs. 979 crores (EBITDA margin of 26%), up by 21% over Hl FY18.
- Net profit at Rs. 342 crores as against Rs. 392 crores in Hl FY18 after considering the following major items:

- Depreciation and amortization is higher by Rs . 138 crores on account of acquired business.
- One time impact of product recall in US of Rs. 25 crores.
- Lower hedging gains due to rupee depreciation.

- R&D spend at Rs. 263 crores against Rs. 208 crores in Hl FY18.

Shares of TORRENT PHARMACEUTICALS LTD. was last trading in BSE at Rs.1630.35 as compared to the previous close of Rs. 1711.45. The total number of shares traded during the day was 11382 in over 1082 trades.

The stock hit an intraday high of Rs. 1740 and intraday low of 1617.65. The net turnover during the day was Rs. 19045860.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Confluence 2019 by Mahindra World City delves into 'Thinking Cities: The Rise of Resilience'

Uflex Honoured with 'Excellence in Packaging -Beverages' at The ET Polymers Awards 2019

Vikram Thermo India Ltd posts net profit of Rs. 0.60 crore in Q3

Lumax Auto Technologies Ltd updates on the PCB business

Robert Bosch Automotive Steering GmbH terminates JV agreement with ZF Steeting Gear India Ltd

Karnataka Bank bags ET Now - BFSI Awards

V-Mart Retail Ltd opens new store in Bihar, closes one

KPI Global bags order of 213.75KW Solar Power Plant under Captive Power Producer

Karnataka Bank shifts its Arehalli Branch to new premises on 16-02-2019

Shalby Hospitals Bestowed With Best IT Enabled Hospital Award 2019

PNC Infratech bags Rs.186 crore PWD road project in UP

Karnataka Bank opens its 838th Branch at Mysuru-Ramanuja Road on 16-02-2019

Ujaas Energy to launch E Scooter

Ground breaking Ceremony of Hooghly Cochin Shipyard Limited's New Yard Construction at Nazirgunge, Kolkata

Dr. Reddy's Laboratories Ltd receives EIR for Formulations Unit at Duvvada, Vizag

Karnataka Bank introduces 475 days special term deosit Scheme

Tech Mahindra Ltd board to consider buy back on Feb 21, 2019

Megasoft announces third quarter results for FY19

HCL Technologies and IBM Collaborate to Accelerate Clients' Hybrid Cloud Journey

Simplex Infra announces Q3FY19 results

Seya Industries Ltd 9MFY19: Sustained Momentum in Business

Alembic Pharmaceuticals announces USFDA Approval for Moxifloxacin Ophthalmic Solution USP 1 0.5%.

Gujarat Terce Laboratories Ltd launces Acolate Plus Tablet

BEML at Aero Show

HOCL approves proposal for sale of 8.08 acres land at Panvel

NIIT recognised as 'Best Training Institution' at the 9th Indian Education Congress at Awards 2019

Sonata Software completes acquisition of Sopris Systems LLC

Karda Constructions Limited announces 3QFY2019 results

Diligent Media Corporation Limited concludes sale of leasehold land for Rs. 57.32 crores

PNC launches streaming of movies on Netflix

Lupin launches Clobazam Oral Suspension, 2.5mg/ml

Technocraft Industries India Ltd opens operations in New Zealand

TRF Ltd approves issue of NCRPS to Tata Steel Ltd

Raminfo Q3 FY19 net profit increases 14.3% with revenue being Rs. 7.60 Crs

Paramount Communications Ltd bags order of Rs. 69.53 crores

ICRA assigns ratings to Nahar Industrial Enterprises Ltd

Sun Pharma returns product rights of Elepsia™ XR back to SPARC

NBCC India Ltd submits resolution plan for Jaypee Infratech Ltd

Lumax Industries Ltd announces setting up of in-house Electronic Facilities

IDFC FIRST Bank to sell stake in Digikredit

Karnataka Bank MD & CEO Shri Mahabaleshwara M S, conferred with 'CEO with HR Orientation Award'

Aanchal Ispat Ltd reports jump in Q3 PAT to Rs. 2.21 crores

Celestial Biolabs Ltd Q3 net profit slides to Rs. 0.07 crore

Donear Industries Ltd reports Q3 FY19 net profit of Rs. 5.14 crores

Mindteck Reports Financial Results for the Third Quarter Ending December 31, 2018

India Home Loan Ltd board approves fund raising proposal through warrants

Mangalore Chemicals & Fertilizers Ltd updates on annual maintenance

Zensar on the path of Rapid Innovation

ONGC board declares interim dividend of Rs. 5.25

Stovec Industries Ltd board recommends final dividend of Rs. 55







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019